Publications by authors named "Randy Bennett"

Claim this Profile
C
Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter, Phase IIIb REFORMS study.
Barry Singer, Daniel Bandari, Mark Cascione, Christopher LaGanke, John Huddlestone, Randy Bennett

BMC Neurol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to recommended dosing and monitoring for mitoxantrone in patients with multiple sclerosis: a healthcare claims database study supplemented with medical records--the RETRO study.
Donnie Funch, Heather Norman, Judy Wong, Randy Bennett, Jill Hillier

Pharmacoepidemiol Drug Saf· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating relapsing multiple sclerosis with subcutaneous versus intramuscular interferon-beta-1a: modelling the clinical and economic implications.
Shien Guo, Duygu Bozkaya, Alexandra Ward, Judith A O'Brien, Khajak Ishak, Randy Bennett

Pharmacoeconomics· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of disease-modifying therapies in relapsing remitting multiple sclerosis: a systematic comparison.
Mark S Freedman, Bruce Hughes, Daniel D Mikol, Randy Bennett, Brian Cuffel

Eur Neurol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to interferon beta-1a treatment in African American multiple sclerosis patients.
Bruce A C Cree, Ahmad Al-Sabbagh, Randy Bennett, Douglas Goodin

Arch Neurol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis